608 related articles for article (PubMed ID: 23733771)
1. Type I and II endometrial cancers: have they different risk factors?
Setiawan VW; Yang HP; Pike MC; McCann SE; Yu H; Xiang YB; Wolk A; Wentzensen N; Weiss NS; Webb PM; van den Brandt PA; van de Vijver K; Thompson PJ; ; Strom BL; Spurdle AB; Soslow RA; Shu XO; Schairer C; Sacerdote C; Rohan TE; Robien K; Risch HA; Ricceri F; Rebbeck TR; Rastogi R; Prescott J; Polidoro S; Park Y; Olson SH; Moysich KB; Miller AB; McCullough ML; Matsuno RK; Magliocco AM; Lurie G; Lu L; Lissowska J; Liang X; Lacey JV; Kolonel LN; Henderson BE; Hankinson SE; Håkansson N; Goodman MT; Gaudet MM; Garcia-Closas M; Friedenreich CM; Freudenheim JL; Doherty J; De Vivo I; Courneya KS; Cook LS; Chen C; Cerhan JR; Cai H; Brinton LA; Bernstein L; Anderson KE; Anton-Culver H; Schouten LJ; Horn-Ross PL
J Clin Oncol; 2013 Jul; 31(20):2607-18. PubMed ID: 23733771
[TBL] [Abstract][Full Text] [Related]
2. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
Brinton LA; Felix AS; McMeekin DS; Creasman WT; Sherman ME; Mutch D; Cohn DE; Walker JL; Moore RG; Downs LS; Soslow RA; Zaino R
Gynecol Oncol; 2013 May; 129(2):277-84. PubMed ID: 23485770
[TBL] [Abstract][Full Text] [Related]
3. Endometrioid endometrial adenocarcinoma: an increase of G3 cancers?
Mang C; Birkenmaier A; Cathomas G; Humburg J
Arch Gynecol Obstet; 2017 Jun; 295(6):1435-1440. PubMed ID: 28421274
[TBL] [Abstract][Full Text] [Related]
4. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
Sturgeon SR; Sherman ME; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Brinton LA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):231-5. PubMed ID: 9521439
[TBL] [Abstract][Full Text] [Related]
5. [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].
Gottwald L; Chałubińska J; Moszyńska-Zielińska M; Piekarski J; Tyliński W; Szwalski J; Kubiak R; Pasz-Walczak G; Hendzel K; Ciałkowska-Rysz A
Ginekol Pol; 2011 Oct; 82(10):743-8. PubMed ID: 22379937
[TBL] [Abstract][Full Text] [Related]
6. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
[TBL] [Abstract][Full Text] [Related]
7. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia.
Matsuo K; Ramzan AA; Gualtieri MR; Mhawech-Fauceglia P; Machida H; Moeini A; Dancz CE; Ueda Y; Roman LD
Gynecol Oncol; 2015 Nov; 139(2):261-7. PubMed ID: 26238457
[TBL] [Abstract][Full Text] [Related]
8. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
10. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
11. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
13. Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer.
Matsuo K; Cahoon SS; Yoshihara K; Shida M; Kakuda M; Adachi S; Moeini A; Machida H; Garcia-Sayre J; Ueda Y; Enomoto T; Mikami M; Roman LD; Sood AK
Obstet Gynecol; 2016 Jul; 128(1):127-137. PubMed ID: 27275802
[TBL] [Abstract][Full Text] [Related]
14. Pathological findings in early-stage endometrial cancer.
Zehavi S; Schneider D; Bukovsky I; Halperin R
Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
[TBL] [Abstract][Full Text] [Related]
15. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis.
Chia VM; Newcomb PA; Trentham-Dietz A; Hampton JM
Int J Gynecol Cancer; 2007; 17(2):441-6. PubMed ID: 17362320
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
Farrell R; Dixon SC; Carter J; Webb PM
Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
[TBL] [Abstract][Full Text] [Related]
17. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
18. Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.
Worley MJ; Davis M; Berhie SH; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Campos SM
Gynecol Oncol; 2014 Oct; 135(1):54-7. PubMed ID: 25088333
[TBL] [Abstract][Full Text] [Related]
19. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.
Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S
Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888
[TBL] [Abstract][Full Text] [Related]
20. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
Tambouret R; Clement PB; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
